Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 02/11/2025 12:35:43 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 7642
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
70896
Update out
stocker11
11/18/2021 8:38:53 AM
70895
Innovation Pharmaceuticals Provides Brilacidin
(4)
bettingbig
11/18/2021 8:38:01 AM
70892
"...Florida teacher hospitalized with COVID-19
(2)
farrell
11/16/2021 2:07:28 PM
70891
No way to know that all analysis has been
(5)
bandg
11/16/2021 11:04:31 AM
70890
The CRO is doing/has completed all the data
(3)
petemantx
11/16/2021 10:53:53 AM
70889
Heparin interacts with the main protease of
Boneysteak
11/16/2021 6:23:50 AM
70888
While most of us view them as the elephant in the
(8)
DrTim
11/15/2021 7:45:18 PM
70886
LOL - That's about PAR for the course. Don't know
NotRichYet2
11/15/2021 11:21:58 AM
70885
He's a Big Pharma insider who will continue
(2)
Drano
11/15/2021 11:07:27 AM
Newer
Older
Recent Articles
Innovative Testing Takes Center Stage in Industry Updates
Insights into Innovative Testing Strategies and Technologies
Unmissable Savings on Monport Laser Engraving Machines Today
Trillion Energy Engages in Strategic Debt Settlements for Growth
Lancaster Resources Set to Finalize Lake Cargelligo Gold Project Deal
New Wave Holdings Successfully Closes Private Placement Funding
Hydreight Technologies Achieves Impressive Q1 Revenue Growth
Innovative Treatments for Patients with Limited Options
New Research Highlights Risks of EV Fire Suppression Methods
Eat & Beyond Announces Strategic Shift with Name Change
Extended Submission Deadline for OpenSSL Conference 2025 Proposals
Kiley Grombacher Honored Among Top Women Lawyers for 2025
Art Garfunkel Delivers Powerful Concert with Son Amid Conflict
Patricia Oliver from PARRIS Law Firm Celebrated in Legal Community
Vortex Energy Corp. Launches Dynamic New Marketing Initiative
Integral Metals Plans Significant Private Placement Offering Soon
Experience Comfort with CASEKOO's Magical New Collection
Global Tobacco Experts Highlight Urgent Need for Action Against Nicotine
Ohdoki's The Handy 2 Sets New Kickstarter Milestones
Waaree Solar Americas Secures Major 586 MW Supply Deal
AIxMed Partners with CorePlus to Enhance Cytology Diagnostics
Elevate Your Understanding of Elevance Health's Legal Challenge
Digi Power X Launches $100 Million Fund to Drive Expansion
Galway Metals Concludes Successful Private Placement Funding
Transcripta Bio and Microsoft Research Join Forces for AI in Medicine
Pickle Juice® Gains Momentum with New Growth Investment
Exciting Expansion of LGI Homes at Star Valley Tucson
Key Insights for OGN Stockholders Affected by Recent Events
Understanding the Recent Class Action Against DoubleVerify Holdings
Calamos Structured ETFs Offer Cap Rates with Downside Protection
Wellness Pet Company Secures $100 Million for Growth Vision
GAP Secures Major Ps. 3,375 Million Credit for Growth
Celularity Faces Nasdaq Compliance Challenge with Form 10-Q
First Quantum Advances Sustainable Management at Cobre Panamá
Results from Sandstorm Gold Royalties Annual Shareholder Meeting
Successful Launch of the Eighth GPS III Satellite by Lockheed
Tempus AI Faces Class Action Investigation: What Investors Need to Know
EnviroGold Welcomes New Interim CFO as Company Evolves
Red White & Bloom Brands Update on Annual Filings Progress
Realty ONE Group Expands Its Global Footprint to New Markets
Florida's Action Drives Healthcare Price Transparency Forward
Brent Emore Takes Charge as CEO of AHF Products: A New Era
Neuberger Berman Fund Declares Monthly Distribution Update
9F Inc. Secures Nasdaq Compliance Extension Amid Challenges
Neuberger Berman Fund Declares Monthly Distribution Increase
Neuberger Berman Real Estate Fund Reveals Monthly Distribution
EpicQuest Education Secures $1.8 Million Through Private Offering
Understanding the Implications of the Semler Scientific Case
Sun Life Announces New Dividend Rates for Preferred Shares
Terra Balcanica Resources Corp Enhances Private Placement Offer